Covered recipient · General Payments record
KEILER MORENO RIVERO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,356.92
- Reported across 64 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.33 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $96.65 | 5 |
| Lilly USA, LLC | $62.37 | 3 |
| Amgen Inc. | $42.18 | 2 |
| PFIZER INC. | $26.37 | 1 |
| DEXCOM, INC. | $25.30 | 1 |
| Abbott Laboratories | $24.16 | 1 |
| Phadia US Inc. | $23.57 | 1 |
| Novo Nordisk AS | $16.93 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.16 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125177109 | CMS |
| ABBVIE INC. | $22.35 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064998 | CMS |
| ABBVIE INC. | $18.01 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105065000 | CMS |
| ABBVIE INC. | $21.75 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105065002 | CMS |
| ABBVIE INC. | $14.88 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105065004 | CMS |
| ABBVIE INC. | $19.66 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105065006 | CMS |
| Amgen Inc. | $25.33 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117332436 | CMS |
| Amgen Inc. | $16.85 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117332438 | CMS |
| Dexcom, Inc. | $25.30 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153313525 | CMS |
| Lilly USA, LLC | $23.90 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135103891 | CMS |
| Lilly USA, LLC | $19.24 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135101819 | CMS |
| Lilly USA, LLC | $19.23 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135125240 | CMS |
| Novo Nordisk Inc | $16.93 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097256099 | CMS |
| PFIZER INC. | $26.37 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131117110 | CMS |
| Phadia US Inc. | $23.57 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067581458 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.80 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601329 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.